220
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Simultaneous pulmonary administration of celecoxib and naringin using a nebulization-friendly nanoemulsion: A device-targeted delivery for treatment of lung cancer

, ORCID Icon, ORCID Icon, &
Pages 611-622 | Received 13 Dec 2021, Accepted 09 Apr 2022, Published online: 19 May 2022

References

  • Amani A, York P, Chrystyn H, et al. Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. AAPS PharmSciTech. 2010;11(3):1147–1151.
  • Nasr M. Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery. Drug Deliv. 2016;23(4):1444–1452.
  • Ahmed-Farid OAH, Nasr M, Ahmed RF, et al. Beneficial effects of curcumin nano-emulsion on spermatogenesis and reproductive performance in male rats under protein deficient diet model: enhancement of sperm motility, conservancy of testicular tissue integrity, cell energy and seminal plasma amino acids content. J Biomed Sci. 2017;24(1):66.
  • Nasr M, Abdel-Hamid S, Moftah NH, et al. Jojoba oil soft colloidal nanocarrier of a synthetic retinoid: preparation, characterization and clinical efficacy in psoriatic patients. Curr Drug Deliv. 2017;14(3):426–432. PubMed PMID: 27174314; eng.
  • Raviadaran R, Ng MH, Chandran D, et al. Stable W/O/W multiple nanoemulsion encapsulating natural tocotrienols and caffeic acid with cisplatin synergistically treated cancer cell lines (A549 and HEP G2) and reduced toxicity on normal cell line (HEK 293). Mater Sci Eng C. 2021;121:111808. 2021 February 01/.
  • Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66(2):227–243.
  • Lovelyn C, Attama AA. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol. 2011;2(5):626–639.
  • McClements DJ. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter. 2012;8(6):1719–1729.
  • Nesamony J, Kalra A, Majrad MS, et al. Development and characterization of nanostructured mists with potential for actively targeting poorly water-soluble compounds into the lungs. Pharm Res. 2013;30(10):2625–2639.
  • Nesamony J, Shah IS, Kalra A, et al. Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation. Drug Dev Ind Pharm. 2014;40(9):1253–1263.
  • Shah K, Chan LW, Wong TW. Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment. Drug Deliv. 2017;24(1):1631–1647.
  • Arbain NH, Salim N, Wui WT, et al. Optimization of quercetin loaded palm oil ester based nanoemulsion formulation for pulmonary delivery. J Oleo Sci. 2018;67(8):933–940.
  • Arbain NH, Basri M, Salim N, et al. Development and characterization of aerosol nanoemulsion system encapsulating low water soluble quercetin for lung cancer treatment. Mater Today Proc. 2018;5:S137–S142.
  • Sivakumar M, Tang SY, Tan KW. Cavitation technology – a greener processing technique for the generation of pharmaceutical nanoemulsions. Ultrason Sonochem. 2014 ;21(6):2069–2083.
  • Li J, Hwang I-C, Chen X, et al. Effects of chitosan coating on curcumin loaded nano-emulsion: study on stability and in vitro digestibility. Food Hydrocoll. 2016;60:138–147.
  • Choi SJ, McClements DJ. Nanoemulsions as delivery systems for lipophilic nutraceuticals: strategies for improving their formulation, stability, functionality and bioavailability. Food Sci Biotechnol. 2020;29(2):149–168.
  • Jafari SM, He Y, Bhandari B. Optimization of nano-emulsions production by microfluidization. European Food Res and Tech. 2007;225(5):733–741.
  • Qian C, McClements DJ. Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle size. Food Hydrocoll. 2011;25(5):1000–1008.
  • Tang SY, Sivakumar M. A novel and facile liquid whistle hydrodynamic cavitation reactor to produce submicron multiple emulsions. AIChE J. 2013;59(1):155–167.
  • Manickam S, Sivakumar K, Pang CH. Investigations on the generation of oil-in-water (O/W) nanoemulsions through the combination of ultrasound and microchannel. Ultrason Sonochem. 2020 2020 December 01;69:105258.
  • Lemjabbar-Alaoui H, Hassan OUI, Yang Y-W, et al. Lung cancer: biology and treatment options. Biochim Biophys Acta Rev Cancer. 2015;1856(2):189–210.
  • Said-Elbahr R, Nasr M, Alhnan MA, et al. Nebulizable colloidal nanoparticles co-encapsulating a COX-2 inhibitor and a herbal compound for treatment of lung cancer. Eur J Pharm Biopharm. 2016;103:1–12.
  • Asmawi AA, Salim N, Ngan CL, et al. Excipient selection and aerodynamic characterization of nebulized lipid-based nanoemulsion loaded with docetaxel for lung cancer treatment. Drug Deliv Transl Res. 2019;9(2):543–554.
  • Sardeli C, Zarogoulidis P, Kosmidis C, et al. Inhaled chemotherapy adverse effects: mechanisms and protection methods. Lung Cancer Management. 2019;8(4):LMT19. PubMed PMID: 31983927.
  • Baba Shekh AO, Abdul Wahab R, Yahya NA. Formulation of roselle extract water-in-oil nanoemulsion for controlled pulmonary delivery. J Dispers Sci Technol. 2022;1–12. DOI:10.1080/01932691.2022.2046044
  • Wong TW. Choice of nanocarrier for pulmonary delivery of cancer therapeutics. Expert Opin Drug Deliv. 2020;17(1):5–7.
  • Lee W-H, Loo C-Y, Traini D, et al. Inhalation of nanoparticle-based drug for lung cancer treatment: advantages and challenges. Asian J Pharm Sci. 2015;10(6):481–489.
  • Md S, Alhakamy NA, Aldawsari HM, et al. Formulation design, statistical optimization, and in vitro evaluation of a naringenin nanoemulsion to enhance apoptotic activity in A549 lung cancer cells. Pharmaceuticals. 2020;13(7):152. PubMed PMID:. Doi:10.3390/ph13070152
  • Md S, Alhakamy NA, Alharbi WS, et al. Development and evaluation of repurposed etoricoxib loaded nanoemulsion for improving anticancer activities against lung cancer cells. Int J Mol Sci. 2021;22(24):13284. PubMed PMID: Doi:10.3390/ijms222413284.
  • Arzhavitina A, Steckel H. Surface active drugs significantly alter the drug output rate from medical nebulizers. Int J Pharm. 2010;384(1):128–136.
  • Beck-Broichsitter M, Gauss J, Gessler T, et al. Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles. J Aerosol Med Pulm Drug Deliv. 2010;23(1):47–57.
  • Videira M, Almeida AJ, Fabra À. Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect. Nanomedicine. 2012;8(7):1208–1215.
  • Nasr M, Taha I, Hathout RM. Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route. Drug Deliv. 2013;20(8):311–318.
  • Paranjpe M, Finke JH, Richter C, et al. Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application. Int J Pharm. 2014;476(1):41–49.
  • Paranjpe M, Muller-Goymann CC. Nanoparticle-mediated pulmonary drug delivery: a review. Int J Mol Sci. 2014;15(4):5852–5873.
  • Weber S, Zimmer A, Pardeike J. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art. Eur J Pharm Biopharm. 2014;86(1):7–22.
  • Rudokas M, Najlah M, Alhnan MA, et al. Liposome delivery systems for inhalation: a critical review highlighting formulation issues and anticancer applications. Med Princ Pract. 2016;25(Suppl. 2):60–72.
  • Khan I, Apostolou M, Bnyan R, et al. Paclitaxel-loaded micro or nano transfersome formulation into novel tablets for pulmonary drug delivery via nebulization. Int J Pharm. 2020;575:118919.
  • Ghazanfari T, Elhissi AMA, Ding Z, et al. The influence of fluid physicochemical properties on vibrating-mesh nebulization. Int J Pharm. 2007;339(1):103–111.
  • Elhissi AMA, Faizi M, Naji WF, et al. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures. Int J Pharm. 2007;334(1):62–70.
  • Elhissi AMA, Giebultowicz J, Stec AA, et al. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients. Int J Pharm. 2012;436(1):519–526.
  • Elhissi A, Hidayat K, Phoenix DA, et al. Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology. Int J Pharm. 2013;444(1):193–199.
  • Najlah M, Parveen I, Alhnan MA, et al. The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers. Int J Pharm. 2014;461(1):234–241.
  • Nasr M, Najlah M, D’Emanuele A, et al. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization. Int J Pharm. 2014;461(1):242–250.
  • Dailey LA, Schmehl T, Gessler T, et al. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features. J Control Release. 2003;86(1):131–144.
  • Alkreathy HM, Alkhatib MH, Al Musaddi SA, et al. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma. Clin Exp Pharmacol Physiol. 2019;46(5):496–505.
  • Huang H, Belwal T, Liu S, et al. Novel multi-phase nano-emulsion preparation for co-loading hydrophilic arbutin and hydrophobic coumaric acid using hydrocolloids. Food Hydrocoll. 2019;93:92–101.
  • Khuroo T, Verma D, Talegaonkar S, et al. Topotecan–tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential. Int J Pharm. 2014;473(1):384–394.
  • Jabri T, Imran M, Aziz A, et al. Design and synthesis of mixed micellar system for enhanced anticancer efficacy of Paclitaxel through its co-delivery with naringin. Drug Dev Ind Pharm. 2019;45(5):703–714.
  • Bharti S, Rani N, Krishnamurthy B, et al. Preclinical evidence for the pharmacological actions of naringin: a review. Planta Med. 2014;80(6):437–451.
  • Chen M, Peng W, Hu S, et al. miR‑126/VCAM‑1 regulation by naringin suppresses cell growth of human non‑small cell lung cancer. Oncol Lett. 2018;16(4):4754–4760.
  • Hida T, K-i K, Muramatsu H, et al. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res. 2000;6(5):2006–2011.
  • Fulzele SV, Shaik MS, Chatterjee A, et al. Anti-cancer effect of celecoxib and aerosolized docetaxel against human non-small cell lung cancer cell line, A549. J Pharm Pharmacol. 2006;58(3):327–336.
  • Patel SK, Zhang Y, Pollock JA, et al. Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions—in vitro study. PLOS ONE. 2013;8(2):e55802.
  • Üner M, Yener G, Ergüven M. Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia. Mater Sci Eng C. 2019;103:109874.
  • Nasr M, Nawaz S, Elhissi A. Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. Int J Pharm. 2012;436(1):611–616.
  • Al Ayoub Y, Gopalan RC, Najafzadeh M, et al. Development and evaluation of nanoemulsion and microsuspension formulations of curcuminoids for lung delivery with a novel approach to understanding the aerosol performance of nanoparticles. Int J Pharm. 2019;557:254–263.
  • Lee WD, Liang YJ, Chen BH. Effects of tanshinone nanoemulsion and extract on inhibition of lung cancer cells A549. Nanotechnology. 2016;27(49):495101.
  • Tagne J-B, Kakumanu S, Ortiz D, et al. A nanoemulsion formulation of tamoxifen increases its efficacy in a breast cancer cell line. Mol Pharm. 2008;5(2):280–286.
  • Prabhakar K, Afzal SM, Surender G, et al. Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain. Acta Pharm Sin B. 2013;3(5):345–353.
  • Patel SK, Beaino W, Anderson CJ, et al. Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model. Clin Immunol. 2015;160(1):59–70.
  • Makled S, Nafee N, Boraie N. Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor. Int J Pharm. 2017;517(1):312–321.
  • Bali V, Ali M, Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces. 2010;76(2):410–420.
  • El-Gogary I, Gaber SAA R, Nasr M. Polymeric nanocapsular baicalin: chemometric optimization, physicochemical characterization and mechanistic anticancer approaches on breast cancer cell lines. Sci Rep. 2019;9(1):11064.
  • El-Kayal M, Nasr M, Elkheshen S, et al. Colloidal (-)-epigallocatechin-3-gallate vesicular systems for prevention and treatment of skin cancer: a comprehensive experimental study with preclinical investigation. Eur J Pharm Sci. 2019;137:104972.
  • Aldalaen S, El-Gogary RI, Nasr M. Fabrication of rosuvastatin-loaded polymeric nanocapsules: a promising modality for treating hepatic cancer delineated by apoptotic and cell cycle arrest assessment. Drug Dev Ind Pharm. 2019;45(1):55–62.
  • Elaasser MM, Abdel-Aziz MM, El-Kassas RA. Antioxidant, antimicrobial, antiviral and antitumor activities of pyranone derivative obtained from Aspergillus candidus. J Microbiol Biotech Res. 2011;1(4):5–17.
  • Nasr M, Awad GAS, Mansour S, et al. Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Eur J Pharm Biopharm. 2011;79(3):601–611.
  • Beck-Broichsitter M, Oesterheld N, Knuedeler M-C, et al. On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery. Int J Pharm. 2014;461(1):34–37.
  • Marple VA, Olson BA, Santhanakrishnan K, et al. Next generation pharmaceutical impactor: a new impactor for pharmaceutical inhaler testing. Part III. extension of archival calibration to 15 L/min. J Aerosol Med. 2004;17(4):335–343.
  • Zhang X, Liu Q, Hu J, et al. An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation. Acta Pharm Sin B. 2014;4(1):79–85.
  • Khan I, Bahuguna A, Kumar P, et al. In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis. Sci Rep. 2018;8(1):144.
  • Montharu J, Le Guellec S, Kittel B, et al. Evaluation of lung tolerance of ethanol, propylene glycol, and sorbitan monooleate as solvents in medical aerosols. J Aerosol Med Pulm Drug Deliv. 2010;23(1):41–46.
  • Santos-Magalhães NS, Pontes A, Pereira VMW, et al. Colloidal carriers for benzathine penicillin G: nanoemulsions and nanocapsules. Int J Pharm. 2000;208(1):71–80.
  • Gill KK, Nazzal S, Kaddoumi A. Paclitaxel loaded PEG5000–DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation. Eur J Pharm Biopharm. 2011;79(2):276–284.
  • Kumar GP, Divya A. Nanoemulsion based targeting in cancer therapeutics. Med Chem. 2015;5:1–13.
  • Ramzy L, Nasr M, Metwally AA, et al. Cancer nanotheranostics: a review of the role of conjugated ligands for overexpressed receptors. Eur J Pharm Sci. 2017;104:273–292.
  • Shinde P, Hadapsar P. Component screening of miconazole nitrate nanoemulsion. Asian Journal of bio-medical & Pharmaceutical Sciences. 2013;3:33–40.
  • Zhu Z, Wen Y, Yi J, et al. Comparison of natural and synthetic surfactants at forming and stabilizing nanoemulsions: tea saponin, Quillaja saponin, and Tween 80. J Colloid Interface Sci. 2019;536:80–87.
  • Rajinikanth P, Keat NW, Garg S. Self-nanoemulsifying drug delivery systems of Valsartan: preparation and in-vitro characterization. Int J Drug Delivery. 2012;4(2):153.
  • Ismail A, Nasr M, Sammour O. Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: improved pharmacokinetic/pharmacodynamic properties. Int J Pharm. 2020;583:119402.
  • Kelmann RG, Kuminek G, Teixeira HF, et al. Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process. Int J Pharm. 2007;342(1):231–239.
  • Constantinides PP, Lambert KJ, Tustian AK, et al. Formulation development and antitumor activity of a filter-sterilizable emulsion of Paclitaxel. Pharm Res. 2000;17(2):175–182.
  • Fang J-Y, Hung C-F, Hua S-C, et al. Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells. Ultrasonics. 2009;49(1):39–46.
  • Ganta S, Amiji M. Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm. 2009;6(3):928–939.
  • Yuan Y, Gao Y, Zhao J, et al. Characterization and stability evaluation of β-carotene nanoemulsions prepared by high pressure homogenization under various emulsifying conditions. Food Res Int. 2008;41(1):61–68.
  • Gaumet M, Vargas A, Gurny R, et al. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 2008;69(1):1–9.
  • Tsujino I, Yamazaki T, Masutani M, et al. Effect of Tween-80 on cell killing by etoposide in human lung adenocarcinoma cells. Cancer Chemother Pharmacol. 1999;43(1):29–34.
  • Shang L, Nienhaus K, Nienhaus GU. Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnology. 2014;12(1):5.
  • Chang HB, Chen BH. Inhibition of lung cancer cells A549 and H460 by curcuminoid extracts and nanoemulsions prepared from curcuma longa linnaeus. Int J Nanomedicine. 2015;10:5059–5080.
  • Mittal G, Kumar N, Rawat H, et al. A radiometric study of factors affecting drug output of jet nebulizers. Indian J Pharm Sci. 2010;72(1):31–38.
  • LiPuma JJ, Rathinavelu S, Foster BK, et al. In Vitro activities of a novel nanoemulsion against burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species. Antimicrob Agents Chemother. 2009;53(1):249–255.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.